Strontium 227 mg Capsules

Strontium is a trace mineral similar to calcium in make up. It may be necessary for proper bone & teeth preservation. A researcher in Canada who has done research on strontium believes that the human diet probably contains insufficient quantities of strontium, and may need to be supplemented. The human body absorbs strontium as if it were calcium (take it at a separate time from your calcium so they don't compete for absorption). A recent in-vitro study conducted the NY College of Dental Sciences using strontium on osteoblasts (bone building cells) showed marked improvement on bone-building osteoblasts.

There is a long history of medical research regarding strontium's benefits, beginning in the 1950s. Studies indicate a lack of undesirable side-effects. Several other salts of strontium such as strontium citrate or strontium carbonate are available in the United States under the Dietary Supplements Health and Education Act of 1994, providing close to the recommended strontium content, about 680 milligrams per day, of strontium ranelate. Their long-term safety and efficacy have not been evaluated on humans in large-scale medical trials.

Serving Size: 1 capsule
Servings Per Container: 90

Active Ingredients:

• strontium (citrate) 227 mg.
• vitamin C (as ascorbyl palmitate) 20 mg.

Inactive Ingredients: Vegetable cellulose, (hypo-allergenic plant fiber added to complete capsule volume requirement)

Recommended Dosage:
As a dietary supplement, take1-3 capsules per day, in divided doses, with or between meals, away from calcium-containing foods or supplements

Warning: If pregnant, consult your physician before taking this or any other product.

Keep this product out of the reach of children.

This encapsulated product contains no hidden coatings, excipients, binders, fillers, artificial colors or fragrance. Contains no dairy, wheat, yeast, starch, soy, preservatives or hydrogenated oils.

References:

1. ^"The Effects of Strontium Citrate on Osteoblast Proliferation and Differentiation" . Retrieved 2009-07-07.
2. ^Meunier P. J., Roux C., Seeman E. et al. (Jan 2004). "effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.". New England Journal of Medicine 350 (5): 459468. PMID 14749454.
3. ^Reginster JY, Seeman E, De Vernejoul MC et al. (May 2005)."Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study" (Free full text). J Clin Metab. 90 (5): 28162822.
4. ^ Mashiba, T; Hirano, T; Turner, CH; Forwood, MR; Johnston, CC; Burr, DB (2000). "Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.". Journal of Bone and Mineral Research 15 (4): 61320. PMID 10780852.
5. ^ Losee, FL; Adkins, BL (1969). "A study of the mineral environment of caries-resistant Navy recruits.". Caries research 3 (1): 2331. PMID 5268322.
6. ^Meunier, PJ; Roux, C; Seeman, E; Ortolani, S; Badurski, JE; Spector, TD; Cannata, J; Balogh, A et al. (2004). "The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.". The New England journal of medicine 350 (5): 45968. doi: 10.1056/NEJMoa022436. PMID 14749454.
7. ^Marie, PJ; Hott, M; Modrowski, D; De Pollak, C; Guillemain, J; Deloffre, P; Tsouderos, Y (1993). "An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.". Journal of Bone and Mineral Research 8 (5): 60715. doi: 10.1002/jbmr.5650080512. PMID 8511988.
8. ^Reginster, JY; Deroisy, R; Dougados, M; Jupsin, I; Colette, J; Roux, C (2002). "Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial.". Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 13 (12): 92531. doi: 10.1007/s001980200129. PMID 12459934.
9. ^Marie, PJ; Ammann, P; Boivin, G; Rey, C (2001). "Mechanisms of action and therapeutic potential of strontium in bone.". Calcified tissue international 69 (3): 1219. doi: 10.1007/s002230010055. . PMID 11683526.